Results 151 to 160 of about 19,221 (177)

The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Obstructive Sleep Apnea and Obesity. [PDF]

Curr Pulmonol Rep
Ellberg CC, Schwartz H, Witt A, McCowen KC, Fuentes AL, Malhotra A.   +5 more
europepmc   +1 more source

Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids. [PDF]

Diabetologia
Guccio N, Alcaino C, Miedzybrodzka EL, Santos-Hernández M, Smith CA, Davison A, Bany Bakar R, Kay RG, Reimann F, Gribble FM.   +9 more
europepmc   +1 more source

The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. [PDF]

J Endocrinol
Kagdi S, Lyons SA, Beaudry JL.
europepmc   +1 more source

Dual Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonist-Associated Thyroiditis: A Case Report of Thyroid Dysfunction Following Tirzepatide Use. [PDF]

Cureus
Humaida S, Manzalji K, Seyam N, Al-Masalmani L.   +3 more
europepmc   +1 more source

Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease.

Endocr Rev
Wolfe MM, Boylan MO, Chin WW.
europepmc   +1 more source

A Case of Severe Cholestatic Hepatitis Induced by a Novel Dual Agonist of Glucagon-like Peptide-1 and Glucose-dependent Insulinotropic Polypeptide Receptors. [PDF]

J Clin Transl Hepatol
Jiang J, Shi M, Wu S, Cao M.
europepmc   +1 more source

Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes? [PDF]

J Endocrinol
Lafferty RA, Flatt PR, Gault VA, Irwin N.   +3 more
europepmc   +1 more source

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists. [PDF]

Cochrane Database Syst Rev
Grenet G, Gougeon A, Salzwedel DM, Jauca CD, Wright JM.   +4 more
europepmc   +1 more source

Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways. [PDF]

J Diabetes Investig
Yada T.
europepmc   +1 more source

DPP4 in diabetes [PDF]

, 2015
Diana Röhrborn
core   +1 more source